Peptides for hair loss: separating real research from TikTok hype

What did @amino.upgrade actually say?

Honestly? It's hard to tell. The transcript attached to this video is not about peptides or hair loss at all. The words captured appear to be song lyrics or garbled audio, not a coherent scientific explanation. The caption mentions BPC-157, PTD-DBM, and growth hormone peptides in the context of scalp circulation and follicle signaling, but the spoken content does not match those claims in any verifiable way.

This matters because fact-checking a video requires knowing what was actually argued. The caption makes three specific claims worth examining on their own merits: that hair loss involves circulation and signaling pathways, that certain peptides are being studied for follicle support, and that scalp health is a meaningful intervention target. Those are worth addressing even if the audio evidence is unreliable.

Does the science back up the caption's claims?

Partially, yes. The biology in the caption is not wrong in principle. Hair follicle cycling does involve vascular signaling, and growth factors play real roles. But the leap from "peptides are being studied" to implying clinical usefulness is where the evidence gets thin fast.

GHK-Cu (copper tripeptide-1) has the strongest hair-related evidence of any peptide mentioned. A study by Puig et al. (2014, Journal of Aging Research) found GHK-Cu could upregulate genes associated with hair follicle growth in vitro. Topical GHK-Cu is already in some over-the-counter products. PTD-DBM has been studied in a single mouse model (Kwack et al., 2019, Journal of Investigative Dermatology), showing it disrupted CXXC5, a protein that suppresses Wnt signaling in follicles. The result was promising but nowhere near human clinical evidence. BPC-157's hair-specific data is essentially nonexistent. Its general angiogenic properties are sometimes extrapolated to scalp circulation, but that extrapolation is speculative.

What did they get wrong (or right)?

The caption gets the biology directionally correct. Hair loss is genuinely not just about genetics. Miniaturization of follicles involves DHT sensitivity, poor microvascular supply, and disrupted Wnt/beta-catenin signaling. Framing it as "circulation, signaling, and scalp health" is a reasonable lay summary of real mechanisms.

What this content gets wrong is the implication of equivalence across peptides. Lumping BPC-157 and GHK-Cu into the same "peptide research for hair" category is misleading. GHK-Cu has topical human data. BPC-157 does not. PTD-DBM has one rodent study. These are not the same category of evidence. Calling all of them "being studied" is technically defensible but functionally misleading to an audience that will treat it as a menu of comparable options.

The audio mismatch is also a real problem. If the video's spoken content has nothing to do with the caption, viewers are being given scientific framing without scientific substance.

What should you actually know?

If you're interested in peptides for hair loss, the honest summary is this: GHK-Cu topically has the most real-world and research support. Minoxidil and finasteride still have the strongest evidence base of any hair loss intervention, with decades of human trial data behind them. Nothing in the peptide space comes close to that bar yet.

BPC-157 is not approved for human use by the FDA and is not a recognized treatment for hair loss. PTD-DBM exists almost entirely in preclinical literature. Growth hormone secretagogues like CJC-1295 or ipamorelin may influence hair indirectly through systemic IGF-1 levels, but using them specifically for hair growth is off-label extrapolation, not established medicine.

Anyone presenting a mix of these compounds as equivalent options for hair support is doing their audience a disservice. The gaps in evidence between them are significant, and the regulatory status of several of them means access through compounding pharmacies involves real legal and safety considerations that no TikTok caption addresses.